Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody- undetectable periods before seroconversion

Blood

Volumn 94, Issue 4, 1999, Pages 1183-1191

  Beld, Marcel ^b   Penning, Maarten ^b   Van Putten, Marieke ^b   Van Den Hoek, Anneke ^b   Damen, Marjolein ^b   Klein, Michèl R ^b   Goudsmit, Jaap ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROCONVERSION;

EID: 0033567053     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.4.1183.416k15_1183_1191     Document Type: Article

References (51)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359, 1989
2. Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE: Correlates of hepatitis C virus infections among injecting drug users. Medicine 74:212, 1995
3. van den Hoek JAR, Goudsmit J, de Wolf F, Coutinho RA: Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 162:823, 1990
4. Rezza G, Sagliocca L, Zaccarelli M, Nespoli M, Siconolfi M, Baldassarre C: Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scan J Infect Dis 28:27, 1996
5. Brunetto MR, Calvo PL, Oliveri F, Colombatto P, Abate ML, Manzini P, Bonino F: Hepatitis C virus infection and liver disease: Peculiar epidemiological and clinicopathological features. FEMS Microbiol Rev 14:259, 1994
6. Esteban R: Epidemiology of hepatitis C virus infection. J Hepatol 17:567, 1993 (suppl 3)
7. De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, Grigioni W, Alberti A, Beaugrand M, Pisi E, Brechot C, Paterlini P: HCV-associated liver cancer without cirrhosis. Lancet 345:413, 1995
8. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo QL, Hughton M, Kuo G: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6547, 1990
9. Alter HJ, Sanchez-Pescador R, Urdea MS, Wilber JC, Lagier RJ, Di Bisceglie AM, Shin JW, Neuwald PD: Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Vir Hepatitis 2:121, 1995
10. Young KK, Resnick RM, Myers TW: Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 31:882, 1993
11. Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda F, Tanaka T, Mishiro S: Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 16:1109, 1992
12. Beld M, Penning M, McMorrow M, Gorgels J, van den Hoek A, Goudsmit J: Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels. J Clin Microbiol 36:872, 1998
13. Lavanchy D, Mayerat C, Morel B, Schneider P, Zufferey C, Gonvers JJ, Pecoud A, Frei PC: Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen. J Clin Microbiol 32:2272, 1994
14. Zaaijer HL, Vrielink H, van Exel-Oehlers PJ, Cuypers HT, Lelie PN: Confirmation of hepatitis C infection: A comparison of five immunoblot assays. Transfusion 34:603, 1994
15. Conry-Cantalena C, VanRaden M, Gibble J, Melpolder J, Obaid Shakil A, Viladomiu L, Ling C, Di Bisceglie A, Hoofnagle J, Kaslow R, Ness P, Alter HJ: Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334:1691, 1996
16. Courouce AM, Bouchardeau F, Chauveau P, Le Marrec N, Girault A, Zins B, Naret C, Poignet JL: Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-R NA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transpl 10:234, 1995
17. Mauser-Bunschoten EP, Bresters D, van Drimmelen AA, Roosendaal G, Cuypers HT, Reesink HW, van der Poel CL, van den Berg HM, Lelie PN: Hepatitis C infection and viremia in Dutch hemophilia patients. J Med Virol 45:241, 1995
18. Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, Rosenblatt J, Choo QL, Houghton M: Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 335:1, 1990
19. Kao JH, Lai MY, Hwang YT, Yang PM, Chen PJ, Sheu JC, Wang TH, Hsu HC, Chen DS: Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay. A clinicopathologic study and demonstration of the usefulness of a third-generation assay. Dig Dis Sci 41:161, 1996
20. Lelie PN, Cuypers HT, Reesink HW, van der Poel CL, Winkel I, Bakker E, van Exel-Oehlers PJ, Vallari D, Allain JP, Mimms L: Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol 37:203, 1992
21. Barrera JM, Bruguera M, Ercilla MG, Gil C, Celis R, Gil MP, del Valle Onorato M, Rodes J, Ordinas A: Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 21:639, 1995
22. Esteban JI, Gomez J, Martell M, Cabot B, Quer J, Camps J, Gonzalez A, Otero T, Moya A, Esteban R, Guardia J: Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 334:555, 1996
23. van Doom LJ, Quint W, Tsiquaye K, Voermans J, Paelinck D, Kos T, Maertens G, Schellekens H, Murray K: Longitudinal analysis of hepatitis C virus infection and genetic drift of the hypervariable region. J Infect Dis 169:1226, 1994
24. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH: Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135, 1992
25. Maple PA, McKee T, Desselberger U, Wreghitt TG: Hepatitis C virus infections in transplant patients: serological and virological investigations. J Med Virol 44:43, 1994
26. Schmidt WN, Wu P, Cederna J, Mitros FA, LaBrecque DR, Stapleton JT: Surreptit ous hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative antibody tests. J Infect Dis 176:27, 1997
27. Schmidt WN, Wu P, Han J-Q, Perino MJ, LaBrecque DR, Stapleton JT: Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: Plasma HCV RNA analysis underestimates circulating virus load. J Infect Dis 176:20, 1997
28. Bassett SE, Brasky KM, Lanford RE: Analysis of hepatis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol 72:2589, 1998
29. Lefrère J-J, Guiramand S, Lefrere F, Mariotti M, Aumont P, Lerable J, Petit J, Girot R, Morand-Joubert L: Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis 175:316, 1997
30. Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, Goudsmit J: Quantitative antibody responses to structural (core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: Impact of epitope variation and relationship to detection of HCV RNA in blood. Hepatology 29:1288, 1999
31. van den Hoek JAR, Coutinho RA, van Haastrecht HJ, van Zadelhoff AW, Goudsmit J: Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 2:55, 1988
32. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28:495, 1990
33. Attia MAM, Zekri A, Goudsmit J, Boom R, Khaled HM, Mansour MT, de Wolf F, El-Din HM, Sol CJA: Diverse patterns of recognition of hepatitis C virus core and non-structural antigens by antibodies present in Egyptian cancer patients and blood donors. J Clin Microbiol 34:2665, 1996
34. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G: Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093, 1993
35. Kumar S, Tamura K, Nei M: MEGA: Molecular evolutionary genetics analysis software for microcomputers. Computer Appl Biosci 10:189, 1994
36. Saitou N, Nei M: The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406, 1987
37. Felsenstein J: Phylogenies from molecular sequences: Inference and reliability. Annu Rev Genet 22:521, 1988
38. Bukh J, Wantzin P, Krogsgaard K, Knudsen F, Purcell RH, Miller RH: High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: Failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J Infect Dis 168:1343, 1993
39. Nübling CM, Seitz R, Löwer J: Application of nucleic acid amplification techniques for blood donation screening. Infusion Ther Transfusion Med 25:86, 1998
40. Tan D, Im SW, Peng WW, Ng MH: Follow-up study of acute hepatitis C. Arch Virol 138:71, 1994
41. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, Farci P: Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343:388, 1994
42. Aquilar C, Lucia JF: Anti-HCV seroreversion in HIV-negative haemophiliacs. Br J Haematol 93:497, 1996
43. Busch MP, Wilber JC, Johnson P, Tobler L, Evans CS: Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 32:420, 1992
44. Cuypers HT, Bresters D, Winkel IN, Reesink HW, Weiner AJ, Houghton M, van der Poel CL, Lelie PN: Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol 30:3220, 1992
45. Beld M, Penning M, van Putten M, van den Hoek A, Lukashov V, McMorrow M, Goudsmit J: Hepatitis C virus serotype-specific Core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies. J Clin Microbiol 36:3002, 1998
46. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M: Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology 20:1131, 1994
47. Prince AM, Brotman B, Huima T, Pascual D, Jaffery M, Inshauspé G: Immunity in hepatitis C infection. J Infect Dis 165:438, 1992
48. Kao JH, Chen PJ, Lai MY, Chen DS: Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis. Gastroenterology 105:583, 1993
49. Laskus T, Wang LF, Rakela J, Vargas H, Pinna AD, Tsamandas AC, Demetris AJ, Fung J: Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology 220:171, 1996
50. Mientjes GH, Miedema F, van Ameijden EJ, van den Hoek JAR, Schellekens PTA, Roos MT, Coutinho RA: Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. AIDS 5:35, 1991
51. Bruisten SM, Mientjes GH, van Delft P, de WolfF, van Ameijden EJ, Comelissen M, Goudsmit J, Coutinho RA, Huisman JG: HIV-1 infection detected by polymerase chain reaction frequently precedes antibody seroconversion in drug users (letter). AIDS 8:1736, 1994